MedTrace Logo

Fractional Flow Reserve Versus Angiography Randomization for Graft Optimization Trial

NCT02477371 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-10-18

No results posted yet for this study

Summary

The FARGO trial is a prospective, randomized (1:1), multicenter study. The aim of the study is to assess the importance of fractional flow reserve (FFR) assessment prior to coronary artery bypass grafting (CABG) with respect to planning and guiding the revascularization strategy. The study compares an FFR-guided strategy to an angiography-guided strategy in patients planned for surgical revascularization.

Conditions

Interventions

PROCEDURE

Fractional flow reserve-guided CABG

Coronary arteries with angiographical significant stenoses, that are planned for grafting at the heart team meeting and where FFR-measurements are made, only receive grafting if FFR-value is ≤ 0,8. Arteries with FFR-values \> 0,8 are deferred.

PROCEDURE

Angiography-guided CABG

Coronary arteries with angiographical significant stenoses, that are planned for grafting at the heart team meeting all receive grafting. FFR-measurements are still made, but not used for guidance of grafting.

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Anne Langhoff Thuesen, MD · Department of Cardio-thoracic surgery, Odense University Hospital

  • Lisette Okkels Jensen, MD,PhD,DMSc · Department of Cardiology, Odense University Hospital

  • Per Thayssen, MD, DMSc · Department of Cardiology, Odense University Hospital

  • Poul Erik Mortensen, MD · Department of Cardio-thoracic surgery, Odense University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02477371 on ClinicalTrials.gov